Autonomix Medical, Inc. (NASDAQ:AMIX) Short Interest Down 16.7% in March

Autonomix Medical, Inc. (NASDAQ:AMIX) was the target of a large decrease in short interest in March. As of March 15th, there was short interest totalling 63,200 shares, a decrease of 16.7% from the February 28th total of 75,900 shares. Based on an average trading volume of 336,700 shares, the days-to-cover ratio is presently 0.2 days. Currently, 3.3% of the company’s stock are short sold.

Autonomix Medical Stock Performance

AMIX opened at $1.73 on Wednesday. Autonomix Medical has a one year low of $1.69 and a one year high of $75.80. The company has a market cap of $4.26 million, a P/E ratio of -0.13 and a beta of -5.40. The business’s 50-day simple moving average is $2.53 and its 200-day simple moving average is $6.07.

Autonomix Medical (NASDAQ:AMIX) last announced its quarterly earnings results on Thursday, February 13th. The company reported ($1.46) EPS for the quarter. As a group, analysts predict that Autonomix Medical will post -10 earnings per share for the current fiscal year.

Institutional Trading of Autonomix Medical

A hedge fund recently bought a new stake in Autonomix Medical stock. Citadel Advisors LLC acquired a new stake in Autonomix Medical, Inc. (NASDAQ:AMIX) in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund acquired 47,884 shares of the company’s stock, valued at approximately $180,000. Citadel Advisors LLC owned about 4.16% of Autonomix Medical at the end of the most recent quarter. 10.78% of the stock is currently owned by hedge funds and other institutional investors.

About Autonomix Medical

Autonomix Medical, Inc, a development stage medical device development company, focuses on advancing technologies for sensing and treating disorders relating to the peripheral nervous system. Its technology platform includes a catheter-based microchip-enabled sensing array to detect and differentiate peripheral neural signals.